Search clinical trials for: Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant

Total 7 results

CHU de Quebec-Universite Laval

Recruiting

A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer.

Prostate Cancer

Canada
CHU de Quebec-Universite Laval
Sunnybrook Health Sciences Centre; Université de Montréal

Completed

HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer (HDRvsLDR)

Prostate Cancer

Canada
British Columbia Cancer Agency
BC Cancer Foundation

Recruiting

LDR vs. HDR Brachytherapy for Prostate Cancer (LDR/HDRmono)

Prostate Cancer

Canada
British Columbia Cancer Agency

Active, not recruiting

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Prostate Cancer

Canada
British Columbia Cancer Agency
Biocompatibles UK Ltd

Completed

Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate (FAST)

Prostate Cancer

Canada
British Columbia Cancer Agency

Recruiting

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) (PROMPT)

Oligometastatic Prostate Cancer

Canada
University Hospital, Grenoble
Clinical Investigation Centre for Innovative Technology Network; Koelis

Recruiting

Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System (FOCUS-BOOST)

Prostate Cancer

France

3

Subscribe